(Q44792559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1 reference

B Huber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

W Bömmel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

I Hauser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

V Horstmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Liem

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Th May

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Meinert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

E Robertson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

L Schulz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Seidel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Tomka-Hoffmeister

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

W Wagner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

Seizure-European Journal of Epilepsy

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

168-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Efficacy of levetiracetam: a review of three pivotal clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Efficacy of levetiracetam in developmentally disabled patients: a review of the literature and six case reports

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Lamotrigine in multihandicapped therapy-resistant epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

Effects of topiramate in patients with epilepsy and intellectual deficits

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2803%2900154-7

7 January 2021

10.1016/S1059-1311(03)00154-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010054%20AND%20SRC:MED&resulttype=core&format=json

release_pzvfhtenrfh35n37h74djtk4em

25 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pzvfhtenrfh35n37h74djtk4em

24 November 2022

mapped directly with Wikidata item

1 reference